Savara Inc. Files 8-K: Material Definitive Agreement

Ticker: SVRA · Form: 8-K · Filed: Oct 30, 2025 · CIK: 1160308

Savara Inc 8-K Filing Summary
FieldDetail
CompanySavara Inc (SVRA)
Form Type8-K
Filed DateOct 30, 2025
Risk Levelmedium
Pages3
Reading Time4 min
Key Dollar Amounts$0.001, $4.20, $4.199
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, company-history

TL;DR

Savara Inc. signed a big deal on Oct 29, 2025. 8-K filed.

AI Summary

On October 29, 2025, Savara Inc. entered into a Material Definitive Agreement. The filing also includes other events and financial statements and exhibits. Savara Inc. was formerly known as Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, and BIOKEYS PHARMACEUTICALS INC.

Why It Matters

This 8-K filing indicates Savara Inc. has entered into a significant agreement, which could impact its business operations and future financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce significant business risks and opportunities that are not yet fully disclosed.

Key Players & Entities

  • Savara Inc. (company) — Registrant
  • October 29, 2025 (date) — Date of earliest event reported
  • Mast Therapeutics, Inc. (company) — Former company name
  • ADVENTRX PHARMACEUTICALS INC (company) — Former company name
  • BIOKEYS PHARMACEUTICALS INC (company) — Former company name

FAQ

What is the nature of the Material Definitive Agreement entered into by Savara Inc. on October 29, 2025?

The filing indicates the entry into a Material Definitive Agreement, but the specific details of the agreement are not provided in this summary.

What other information is included in this 8-K filing besides the Material Definitive Agreement?

The filing also includes 'Other Events' and 'Financial Statements and Exhibits'.

When was Savara Inc. previously known by other names?

Savara Inc. was formerly known as Mast Therapeutics, Inc. (name change March 12, 2013), ADVENTRX PHARMACEUTICALS INC (name change June 13, 2003), and BIOKEYS PHARMACEUTICALS INC (name change September 28, 2001).

What is Savara Inc.'s state of incorporation and fiscal year end?

Savara Inc. is incorporated in Delaware and its fiscal year ends on December 31.

What is the SEC file number and IRS Employer Identification Number for Savara Inc.?

The SEC file number is 001-32157 and the IRS Employer Identification Number is 84-1318182.

Filing Stats: 893 words · 4 min read · ~3 pages · Grade level 10.3 · Accepted 2025-10-30 16:26:01

Key Financial Figures

  • $0.001 — ich registered Common Stock, par value $0.001 per share SVRA The Nasdaq Global Se
  • $4.20 — public offering price of the Shares is $4.20 per share, and the offering price of th
  • $4.199 — ing price of the Pre-Funded Warrants is $4.199 per Pre-Funded Warrant, which represent

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated October 29, 2025, by and among Savara Inc., Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein. 4.1 Form of Pre-Funded Warrant 5.1 Opinion of Polsinelli PC. 23.1 Consent of Polsinelli PC (included in Exhibit 5.1). 99.1 Press Release of Savara Inc., dated October 29, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 30, 2025 SAVARA INC. a Delaware corporation By: /s/ Dave Lowrance Dave Lowrance Chief Financial & Administrative Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.